• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Determination of tenoxicam in human plasma by high-performance liquid chromatography.

作者信息

Heizmann P, Körner J, Zinapold K

出版信息

J Chromatogr. 1986 Jan 10;374(1):95-102. doi: 10.1016/s0378-4347(00)83256-9.

DOI:10.1016/s0378-4347(00)83256-9
PMID:3485110
Abstract

A high-performance liquid chromatographic method for the determination of tenoxicam in plasma has been developed. Tenoxicam was extracted from buffered plasma (pH 3 or 4, respectively) with dichloromethane and the evaporated extracts were analysed on a C18 reversed-phase column using a methanol-phosphate buffer mobile phase and with UV detection at 371 nm. The detection limit was 20 ng/ml using a 0.5-ml sample. The method is selective with respect to the 5'-hydroxy metabolite, which is present in plasma after multiple administration of tenoxicam; this metabolite may also be determined using this procedure.

摘要

相似文献

1
Determination of tenoxicam in human plasma by high-performance liquid chromatography.
J Chromatogr. 1986 Jan 10;374(1):95-102. doi: 10.1016/s0378-4347(00)83256-9.
2
Determination of tenoxicam in plasma by high-performance liquid chromatography.
J Chromatogr. 1993 Jul 2;616(2):349-52. doi: 10.1016/0378-4347(93)80407-u.
3
Determination of tenoxicam, and the isolation, identification and determination of Ro 17-6661, its major metabolite, in human urine.
J Chromatogr. 1984 Dec 28;317:483-92. doi: 10.1016/s0021-9673(01)91688-7.
4
Simple method for the analysis of tenoxicam in human plasma using high-performance liquid chromatography.
J Chromatogr B Biomed Appl. 1995 Mar 24;665(2):410-5. doi: 10.1016/0378-4347(94)00534-c.
5
Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry.液相色谱-串联质谱法同时测定人血浆中的吡罗昔康、美洛昔康和替诺昔康
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Nov 5;826(1-2):214-9. doi: 10.1016/j.jchromb.2005.08.023. Epub 2005 Oct 5.
6
Determination of the novel non-steroidal anti-inflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid.新型非甾体抗炎药氯诺昔康及其主要代谢产物在血浆和滑液中的测定。
J Chromatogr B Biomed Sci Appl. 1998 Apr 10;707(1-2):151-9. doi: 10.1016/s0378-4347(97)00597-5.
7
Simultaneous determination for oxicam non-steroidal anti-inflammatory drugs in human serum by liquid chromatography-tandem mass spectrometry.液相色谱-串联质谱法同时测定人血清中的昔康类非甾体抗炎药。
Forensic Sci Int. 2013 Apr 10;227(1-3):100-2. doi: 10.1016/j.forsciint.2012.11.016. Epub 2012 Dec 27.
8
Analysis of meloxicam by high-performance liquid chromatography with cloud-point extraction.采用浊点萃取-高效液相色谱法分析美洛昔康。
Anal Bioanal Chem. 2008 Nov;392(5):947-53. doi: 10.1007/s00216-008-2333-0. Epub 2008 Aug 27.
9
High-performance liquid chromatographic analysis of piroxicam and tenoxicam in plasma, blood and buffer solution. Application to pharmacokinetic studies in small laboratory animals.血浆、血液及缓冲溶液中吡罗昔康和替诺昔康的高效液相色谱分析。在小型实验动物药代动力学研究中的应用。
Arzneimittelforschung. 1993 Jun;43(6):679-81.
10
Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study.采用带紫外检测的高效液相色谱法测定人血浆中的美洛昔康及其在药代动力学研究中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Nov 1;859(1):69-73. doi: 10.1016/j.jchromb.2007.09.004. Epub 2007 Sep 14.

引用本文的文献

1
Eco-Friendly High-Performance Thin-Layer Chromatography Method for the Determination of Tenoxicam in Commercial Formulations.用于测定市售制剂中替诺昔康的环保型高效薄层色谱法
ACS Omega. 2023 Oct 12;8(42):39936-39944. doi: 10.1021/acsomega.3c07252. eCollection 2023 Oct 24.
2
Development and Validation of HPTLC Method for Estimation of Tenoxicam and its Formulations.用于测定替诺昔康及其制剂的高效薄层色谱法的开发与验证
Indian J Pharm Sci. 2012 Jan;74(1):36-40. doi: 10.4103/0250-474X.102541.
3
Intraocular and plasma kinetics of tenoxicam in rabbits.
Graefes Arch Clin Exp Ophthalmol. 1993 Feb;231(2):115-7. doi: 10.1007/BF00920224.
4
Clinical pharmacokinetics of tenoxicam.替诺昔康的临床药代动力学
Clin Pharmacokinet. 1994 Jan;26(1):16-43. doi: 10.2165/00003088-199426010-00003.
5
Single and multiple dose pharmacokinetics of tenoxicam in the elderly.替诺昔康在老年人中的单剂量和多剂量药代动力学
Eur J Clin Pharmacol. 1988;35(5):563-6. doi: 10.1007/BF00558254.
6
The influence of cholestyramine on the elimination of tenoxicam and piroxicam.消胆胺对替诺昔康和吡罗昔康消除的影响。
Eur J Clin Pharmacol. 1988;34(3):283-9. doi: 10.1007/BF00540957.
7
Plasma tenoxicam concentrations after single and multiple oral doses.
Eur J Drug Metab Pharmacokinet. 1989 Jan-Mar;14(1):23-7. doi: 10.1007/BF03190838.
8
Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide.替诺昔康对同时口服葡萄糖和格列本脲的动态反应无影响。
Br J Clin Pharmacol. 1990 Aug;30(2):245-52. doi: 10.1111/j.1365-2125.1990.tb03771.x.
9
Tenoxicam concentrations in synovium and joint cartilage in humans.人体滑膜和关节软骨中的替诺昔康浓度。
Agents Actions. 1991 Mar;32(3-4):295-8. doi: 10.1007/BF01980889.
10
The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage renal disease.
Eur J Clin Pharmacol. 1992;43(2):197-9. doi: 10.1007/BF01740671.